After an unexpected death in the family, the first question is often “Why?” A quieter but equally difficult question follows: “Could this happen to us?” Sudden cardiac death at a young age can sometimes be the first sign of an inherited cardiomyopathy or heart-rhythm disorder.
That does not mean every sudden death is genetic. Careful records, a clear account of the circumstances, and systematic family assessment can help uncover preventable risks. The goal is not to create fear; it is to turn uncertainty into a medical plan.
What is sudden cardiac death?
Sudden cardiac death is an unexpected death caused by a cardiac condition. Coronary artery disease is common in adults, while inherited conditions such as hypertrophic or arrhythmogenic cardiomyopathy, long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia are considered more carefully in younger people.
Descriptions such as “died in sleep,” “collapsed during sport,” or “looked like a seizure” are not diagnoses, but the context can provide important clues.
When is family evaluation particularly important?
- The death occurred before age 50
- A complete autopsy did not identify a cause
- The event occurred during exercise, emotional stress, a sudden noise, or sleep
- Other relatives have had sudden death, unexplained fainting, or seizure-like events
- The family includes cardiomyopathy, serious arrhythmia, aortic dissection, or a pacemaker/ICD at a young age
Early heart attacks may require a different pathway. See our guide to family history of early heart attack and genetic risk.
The first step is not a gene panel—it is completing the story
Assessment should begin, when possible, with the death certificate, hospital notes, ambulance rhythm strips, toxicology, and the full autopsy report. Previous ECGs, echocardiograms, and symptom records can also be useful. A three-generation pedigree is recorded, replacing vague descriptions such as “died of the heart” with verified diagnoses and ages whenever possible.
This groundwork is often more valuable than ordering a very broad panel without a clinical question.
What is a molecular autopsy?
When a standard autopsy cannot explain the death, genetic analysis of properly stored blood or tissue is sometimes called a molecular autopsy. The 2022 ESC guideline recommends targeted postmortem genetic testing when a person younger than 50 dies suddenly and the circumstances or family history suggest a primary inherited electrical disease.
Not every sample is suitable and not every test provides an answer. Collection, storage, and test selection may require cooperation between forensic medicine, cardiology, and medical genetics.
How are living relatives screened?
Family assessment is more than a blood test. History, physical examination, a 12-lead ECG, and echocardiography are core tests for first-degree relatives. Depending on the case, exercise testing, rhythm monitoring, high-precordial-lead ECG, or cardiac MRI may be added.
If a pathogenic or likely pathogenic variant is found in the deceased person, relatives may be offered targeted testing for that change. If testing is negative—or no DNA sample exists—clinical screening still matters.
What can a genetic result change?
A confirmed disease-causing variant can focus follow-up on relatives who carry it and may influence management in selected conditions. A variant of uncertain significance (VUS), however, should not be used to label relatives as high risk or to justify a preventive device or operation.
For the differences between positive, negative, and uncertain results, read our guide to cardiovascular genetic test results.
Five practical steps a family can take now
- Keep the complete death and autopsy records.
- Write down ages and diagnoses for heart disease, fainting, and sudden death in relatives.
- Arrange clinical cardiac assessment for first-degree relatives.
- Consider genetic testing only with a clear clinical question and counseling.
- Report new diagnoses or events in the family to the treating team.
Takeaway
Sudden cardiac death in a family is not “genetic destiny.” It may point to an inherited condition, or it may have a non-genetic cause. The distinction comes from a complete autopsy, a detailed family history, clinical screening, and targeted genetics when appropriate—not from random testing.
To plan an evaluation, visit our page on cardiovascular genetic testing and counseling or contact us.
Frequently asked questions
Should everyone be genetically tested after one sudden death?
No. The cause of death and the clinical findings in living relatives should be reviewed first. Testing is most informative in the person who best represents the disease or in a suitable postmortem sample.
If the autopsy is normal, does that exclude heart disease?
No. Some inherited electrical disorders leave no structural changes, which is why an unexplained autopsy result can make family evaluation more important.
Should children be screened?
They may need evaluation depending on the suspected condition, age at death, and genetic finding. Timing should be planned with pediatric cardiology and genetics expertise.
Scientific sources: 2022 ESC Guideline on Ventricular Arrhythmias and Sudden Cardiac Death; EHRA/HRS/APHRS/LAHRS consensus on cardiac genetic testing; MedlinePlus patient guide to sudden cardiac arrest.
This article is for general education. Call emergency services for urgent symptoms. Family screening and genetic testing require individual clinical assessment.
